Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Apr 11, 2022
Open Peer Review Period: Apr 11, 2022 - Jun 6, 2022
Date Accepted: Sep 2, 2022
Date Submitted to PubMed: Sep 14, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

Mandal S, Wiesenfeld B, Mann DM, Lawrence K, Chunara R, Testa P, Nov O

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

JMIR Form Res 2022;6(10):e38661

DOI: 10.2196/38661

PMID: 36103553

PMCID: 9578517

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Is virtual care the new normal? Evidence supporting COVID-19’s durable transformation of healthcare delivery

  • Soumik Mandal; 
  • Batia Wiesenfeld; 
  • Devin M. Mann; 
  • Katharine Lawrence; 
  • Rumi Chunara; 
  • Paul Testa; 
  • Oded Nov

ABSTRACT

Background:

Despite the surge of telemedicine use during the early stages of the coronavirus-19 (COVID-19) pandemic, research has not evaluated the extent to which the growth of telemedicine has been sustained during recurring pandemic waves.

Objective:

This study provides data on the long-term durability of video-based telemedicine visits and their impact on urgent and non-urgent healthcare delivery from one large health system in New York City.

Methods:

Electronic health record (EHR) data of patients between January 1st, 2020 and February 28th, 2022 were used to conduct the analyses and longitudinal comparisons of telemedicine or in-person visit volumes. Patients’ diagnosis data were used to differentiate COVID-19 suspected visits from non-COVID-19 ones while comparing the visit types.

Results:

While COVID-19 prompted an increase in telemedicine visits and a simultaneous decline in in-person clinic visits, telemedicine use has stabilized since then for both COVID-19 and non-COVID suspected visits. For COVID-19 suspected visits, utilization of virtual urgent care facilities is higher than the trend. The data further suggests that virtual healthcare delivery supplements, rather than replaces, in-person care.

Conclusions:

The COVID-19 pandemic has transformed the use of telemedicine as a means of healthcare delivery, and the data presented here suggests that this is an enduring transformation. Telemedicine use increased with the surge of infection cases during the pandemic, but evidence suggests that it will persist after the pandemic, especially for younger patients, for both urgent and non-urgent care. These findings have implications for the healthcare delivery system, insurers and policymakers.


 Citation

Please cite as:

Mandal S, Wiesenfeld B, Mann DM, Lawrence K, Chunara R, Testa P, Nov O

Evidence for Telemedicine’s Ongoing Transformation of Health Care Delivery Since the Onset of COVID-19: Retrospective Observational Study

JMIR Form Res 2022;6(10):e38661

DOI: 10.2196/38661

PMID: 36103553

PMCID: 9578517

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.